![Arrowhead Pharmaceuticals, Inc. logo](/logos/ARWR.webp)
Arrowhead Pharmaceuticals, Inc.
NASDAQ:ARWR
Overview | Financials
Company Name | Arrowhead Pharmaceuticals, Inc. |
Symbol | ARWR |
Currency | USD |
Price | 22.22 |
Market Cap | 2,762,279,300 |
Dividend Yield | 0% |
52-week-range | 20.67 - 39.83 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Christopher R. Anzalone Ph.D. |
Website | https://arrowheadpharma.com |
An error occurred while fetching data.
About Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD